Atlas Trials

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Clinical trial NCT00821301 · UNKNOWN

Trial details

NCT number
NCT00821301
Sponsor
Immune Control
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2008-12-01
Primary completion
2010-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.